DIADEMA PARTNERS LP
data from 30/09/2025
Capitalization
$ 390.972 M
19.12 %
Performance
$ 4.729 M
2.15 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | QURE | UNIQURE NV | 4.48% | 17.511 M $ | 300000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | REGN | REGENERON PHARMACEUTICALS | 4.34% | 16.958 M $ | 30160 | 2025/03/31 | 208.972 K $ | 7.10 % |
| 2025/09/30 | SPY | SPDR S&P 500 ETF TR | 3.41% | 13.324 M $ | 20000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | JAZZ | JAZZ PHARMACEUTICALS PLC | 3.37% | 13.180 M $ | 100000 | 2025/03/31 | 1.284 M $ | 24.20 % |
| 2025/09/30 | SLNO | SOLENO THERAPEUTICS INC | 3.07% | 11.988 M $ | 177330 | 2024/12/31 | -4.598 M $ | -19.31 % |
| 2025/09/30 | BMRN | BIOMARIN PHARMACEUTICAL INC | 2.95% | 11.529 M $ | 212877 | 2025/03/31 | -156.230 K $ | -1.47 % |
| 2025/09/30 | VKTX | VIKING THERAPEUTICS INC | 2.72% | 10.646 M $ | 405100 | 2025/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | AGIO | AGIOS PHARMACEUTICALS INC | 2.28% | 8.915 M $ | 222100 | 2024/12/31 | 840.048 K $ | 20.69 % |
| 2025/09/30 | RNA | AVIDITY BIOSCIENCES INC | 2.23% | 8.718 M $ | 200100 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | INCY | INCYTE CORP | 2.17% | 8.481 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | NTLA | INTELLIA THERAPEUTICS INC | 2.08% | 8.120 M $ | 470200 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | BMY | BRISTOL-MYERS SQUIBB CO | 2.08% | 8.118 M $ | 180000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | PCVX | VAXCYTE INC | 2.01% | 7.863 M $ | 218285 | 2024/12/31 | 695.980 K $ | 10.80 % |
| 2025/09/30 | LLY | ELI LILLY & CO | 1.95% | 7.630 M $ | 10000 | 2025/03/31 | -342.170 K $ | -2.12 % |
| 2025/09/30 | CRSP | CRISPR THERAPEUTICS AG | 1.86% | 7.259 M $ | 112000 | 2024/12/31 | 1.811 M $ | 33.24 % |
| 2025/09/30 | BBIO | BRIDGEBIO PHARMA INC | 1.75% | 6.825 M $ | 131400 | 2024/12/31 | 1.151 M $ | 20.29 % |
| 2025/09/30 | SLNO | SOLENO THERAPEUTICS INC | 1.73% | 6.760 M $ | 100000 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | JAZZ | JAZZ PHARMACEUTICALS PLC | 1.69% | 6.590 M $ | 50000 | 2025/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | IONS | IONIS PHARMACEUTICALS INC | 1.67% | 6.542 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | INDV | INDIVIOR PLC | 1.57% | 6.130 M $ | 254252 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | BMY | BRISTOL-MYERS SQUIBB CO | 1.50% | 5.863 M $ | 130000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | MNKD | MANNKIND CORP | 1.43% | 5.582 M $ | 1039500 | 2025/03/31 | 847.437 K $ | 43.58 % |
| 2025/09/30 | NVO | NOVO-NORDISK A S | 1.42% | 5.549 M $ | 100000 | 2025/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | ASND | ASCENDIS PHARMA A/S | 1.40% | 5.482 M $ | 27572 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | PRAX | PRAXIS PRECISION MEDICINES I | 1.36% | 5.300 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | NBIX | NEUROCRINE BIOSCIENCES INC | 1.36% | 5.300 M $ | 37754 | 2025/03/31 | 1.381 M $ | 11.69 % |
| 2025/09/30 | VKTX | VIKING THERAPEUTICS INC | 1.30% | 5.090 M $ | 193689 | 2025/03/31 | -43.442 K $ | -0.83 % |
| 2025/09/30 | APGE | APOGEE THERAPEUTICS INC | 1.29% | 5.062 M $ | 127400 | 2025/03/31 | -578.310 K $ | -8.52 % |
| 2025/09/30 | ALNY | ALNYLAM PHARMACEUTICALS INC | 1.17% | 4.560 M $ | 10000 | 2025/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | ROIV | ROIVANT SCIENCES LTD | 1.16% | 4.539 M $ | 300000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | IMCR | IMMUNOCORE HLDGS PLC | 1.16% | 4.519 M $ | 124384 | 2025/03/31 | 516.700 K $ | 15.77 % |
| 2025/09/30 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 1.15% | 4.512 M $ | 150000 | 2024/12/31 | -1.363 M $ | -17.27 % |
| 2025/09/30 | NKTR | NEKTAR THERAPEUTICS | 1.09% | 4.268 M $ | 75000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | HRMY | HARMONY BIOSCIENCES HLDGS IN | 1.06% | 4.134 M $ | 150000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | UPB | UPSTREAM BIO INC | 0.96% | 3.762 M $ | 200000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SRRK | SCHOLAR ROCK HLDG CORP | 0.95% | 3.724 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 0.95% | 3.709 M $ | 123300 | 2024/12/31 | -774.324 K $ | -17.27 % |
| 2025/09/30 | ABVX | ABIVAX SA | 0.90% | 3.513 M $ | 41620 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | RXRX | RECURSION PHARMACEUTICALS IN | 0.87% | 3.408 M $ | 698400 | 2024/12/31 | -125.711 K $ | -3.56 % |
| 2025/09/30 | PTGX | PROTAGONIST THERAPEUTICS INC | 0.87% | 3.400 M $ | 51185 | 2025/06/30 | 850.224 K $ | 20.19 % |
| 2025/09/30 | SLNO | SOLENO THERAPEUTICS INC | 0.86% | 3.380 M $ | 50000 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | ZYME | ZYMEWORKS INC | 0.86% | 3.356 M $ | 196500 | 2025/03/31 | 812.228 K $ | 36.10 % |
| 2025/09/30 | MREO | MEREO BIOPHARMA GROUP PLC | 0.80% | 3.132 M $ | 1520200 | 2025/03/31 | -856.439 K $ | -23.99 % |
| 2025/09/30 | JAZZ | JAZZ PHARMACEUTICALS PLC | 0.78% | 3.050 M $ | 23140 | 2024/12/31 | 2.683 M $ | 24.20 % |
| 2025/09/30 | ANIP | ANI PHARMACEUTICALS INC | 0.74% | 2.876 M $ | 31400 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | COGT | COGENT BIOSCIENCES INC | 0.73% | 2.872 M $ | 200000 | 2025/06/30 | 49.542 K $ | 100.00 % |
| 2025/09/30 | ARCT | ARCTURUS THERAPEUTICS HLDGS | 0.71% | 2.781 M $ | 150900 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | RVMD | REVOLUTION MEDICINES INC | 0.71% | 2.759 M $ | 59079 | 2025/06/30 | 783.672 K $ | 26.94 % |
| 2025/09/30 | MRNA | MODERNA INC | 0.67% | 2.637 M $ | 102100 | 2025/03/31 | -179.696 K $ | -6.38 % |
| 2025/09/30 | SCPH | SCPHARMACEUTICALS INC | 0.67% | 2.620 M $ | 462000 | 2025/06/30 | 904.889 K $ | 48.82 % |
| 2025/09/30 | MRNA | MODERNA INC | 0.66% | 2.583 M $ | 100000 | 2025/03/31 | -176.000 K $ | -6.38 % |
| 2025/09/30 | REPL | REPLIMUNE GROUP INC | 0.66% | 2.566 M $ | 612300 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | APGE | APOGEE THERAPEUTICS INC | 0.65% | 2.553 M $ | 64250 | 2024/12/31 | -39.116 K $ | -8.52 % |
| 2025/09/30 | TERN | TERNS PHARMACEUTICALS INC | 0.62% | 2.427 M $ | 323159 | 2024/12/31 | 982.240 K $ | 101.34 % |
| 2025/09/30 | ABUS | ARBUTUS BIOPHARMA CORP | 0.60% | 2.344 M $ | 516300 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ARDX | ARDELYX INC | 0.56% | 2.204 M $ | 400000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | CORT | CORCEPT THERAPEUTICS INC | 0.56% | 2.202 M $ | 26500 | 2025/03/31 | 972.941 K $ | 13.23 % |
| 2025/09/30 | TGTX | TG THERAPEUTICS INC | 0.56% | 2.195 M $ | 60748 | 2024/12/31 | 52.002 K $ | 0.39 % |
| 2025/09/30 | GOSS | GOSSAMER BIO INC | 0.55% | 2.169 M $ | 824800 | 2024/12/31 | 1.155 M $ | 113.82 % |
| 2025/09/30 | CAPR | CAPRICOR THERAPEUTICS INC | 0.55% | 2.163 M $ | 300000 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | ALKS | ALKERMES PLC | 0.55% | 2.162 M $ | 72079 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ACAD | ACADIA PHARMACEUTICALS INC | 0.49% | 1.899 M $ | 89000 | 2025/06/30 | -20.447 K $ | -1.07 % |
| 2025/09/30 | ROIV | ROIVANT SCIENCES LTD | 0.46% | 1.816 M $ | 120000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | URGN | UROGEN PHARMA LTD | 0.46% | 1.796 M $ | 90000 | 2024/12/31 | 937.500 K $ | 45.62 % |
| 2025/09/30 | MBX | MBX BIOSCIENCES INC | 0.45% | 1.750 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ALT | ALTIMMUNE INC | 0.45% | 1.746 M $ | 463000 | 2024/12/31 | -126.290 K $ | -2.58 % |
| 2025/09/30 | TERN | TERNS PHARMACEUTICALS INC | 0.43% | 1.691 M $ | 225200 | 2025/06/30 | 608.202 K $ | 101.34 % |
| 2025/09/30 | OCUL | OCULAR THERAPEUTIX INC | 0.41% | 1.598 M $ | 136700 | 2024/12/31 | 329.447 K $ | 25.97 % |
| 2025/09/30 | TECX | TECTONIC THERAPEUTIC INC | 0.40% | 1.569 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SMMT | SUMMIT THERAPEUTICS INC | 0.39% | 1.543 M $ | 74700 | 2024/12/31 | -46.314 K $ | -2.91 % |
| 2025/09/30 | PCRX | PACIRA BIOSCIENCES INC | 0.39% | 1.519 M $ | 58926 | 2025/03/31 | 110.191 K $ | 7.82 % |
| 2025/09/30 | NVAX | NOVAVAX INC | 0.38% | 1.504 M $ | 173500 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | COGT | COGENT BIOSCIENCES INC | 0.36% | 1.405 M $ | 97813 | 2024/12/31 | 2.816 M $ | 100.00 % |
| 2025/09/30 | NVO | NOVO-NORDISK A S | 0.35% | 1.387 M $ | 25000 | 2025/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | HRMY | HARMONY BIOSCIENCES HLDGS IN | 0.35% | 1.381 M $ | 50100 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | HRMY | HARMONY BIOSCIENCES HLDGS IN | 0.35% | 1.378 M $ | 50000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | AMLX | AMYLYX PHARMACEUTICALS INC | 0.35% | 1.359 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | RNA | AVIDITY BIOSCIENCES INC | 0.33% | 1.307 M $ | 30000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | MNMD | MIND MEDICINE MINDMED INC | 0.32% | 1.248 M $ | 105891 | 2024/12/31 | 840.240 K $ | 81.66 % |
| 2025/09/30 | AVXL | ANAVEX LIFE SCIENCES CORP | 0.32% | 1.244 M $ | 139800 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | VTGN | VISTAGEN THERAPEUTICS INC | 0.32% | 1.242 M $ | 349789 | 2024/12/31 | 626.079 K $ | 77.50 % |
| 2025/09/30 | SKYE | SKYE BIOSCIENCE INC | 0.30% | 1.179 M $ | 300000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | CRMD | CORMEDIX INC | 0.30% | 1.163 M $ | 100000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | MNKD | MANNKIND CORP | 0.29% | 1.141 M $ | 212475 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SUPN | SUPERNUS PHARMACEUTICALS INC | 0.27% | 1.068 M $ | 22348 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | EDIT | EDITAS MEDICINE INC | 0.27% | 1.041 M $ | 300000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | FOLD | AMICUS THERAPEUTICS INC | 0.26% | 1.035 M $ | 131400 | 2024/12/31 | 282.509 K $ | 37.52 % |
| 2025/09/30 | CPRX | CATALYST PHARMACEUTICALS INC | 0.25% | 985.000 K $ | 50000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | RVPH | REVIVA PHARMACEUTCLS HLDGS I | 0.24% | 924.051 K $ | 2506921 | 2025/03/31 | -34.193 K $ | -3.28 % |
| 2025/09/30 | ARCT | ARCTURUS THERAPEUTICS HLDGS | 0.23% | 899.587 K $ | 48811 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | OLMA | OLEMA PHARMACEUTICALS INC | 0.23% | 885.995 K $ | 90500 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | TRVI | TREVI THERAPEUTICS INC | 0.20% | 785.345 K $ | 85830 | 2025/03/31 | 683.854 K $ | 67.28 % |
| 2025/09/30 | PBYI | PUMA BIOTECHNOLOGY INC | 0.18% | 721.629 K $ | 135900 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SLS | SELLAS LIFE SCIENCES GROUP I | 0.16% | 644.000 K $ | 400000 | 2025/06/30 | -231.999 K $ | -26.48 % |
| 2025/09/30 | XERS | XERIS BIOPHARMA HOLDINGS INC | 0.16% | 608.489 K $ | 74753 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | CTMX | CYTOMX THERAPEUTICS INC | 0.15% | 591.062 K $ | 185286 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | MRNA | MODERNA INC | 0.13% | 516.600 K $ | 20000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | AYTU | AYTU BIOPHARMA INC | 0.13% | 512.620 K $ | 272670 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | TNYA | TENAYA THERAPEUTICS INC | 0.13% | 511.141 K $ | 315519 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | KOD | KODIAK SCIENCES INC | 0.12% | 455.086 K $ | 27800 | 2025/09/30 | 0.000 $ | 0.00 % |